NYSE:EVHC - Envision Healthcare Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$44.72 +0.02 (+0.04 %)
(As of 06/19/2018 12:14 PM ET)
Previous Close$44.67
Today's Range$44.65 - $44.78
52-Week Range$23.77 - $64.00
Volume536,516 shs
Average Volume6.88 million shs
Market Capitalization$5.41 billion
P/E Ratio18.02
Dividend YieldN/A
Envision Healthcare logoEnvision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services. The company also offers ambulatory surgical centers (ASCs) services that provide surgical procedures across multiple specialties, including gastroenterology, ophthalmology, orthopedics, and others. It operated 264 ASCs in 35 states and the District of Columbia. In addition, it provides surgery services, such as management, oversight, and surgeon staffing for trauma surgery services; offers direct patient care and care coordination by clinicians outside the acute care setting through physician-led post-acute care services; and operates office-based medical practices that primarily focus on women's health, as well as provides physician staffing and related management services. Further, it offers medical transportation services in 41 states and the District of Columbia. The company offers its clinical solutions for health systems, payors, providers, and patients. Envision Healthcare Corporation was founded in 1992 and is based in Nashville, Tennessee.

Receive EVHC News and Ratings via Email

Sign-up to receive the latest news and ratings for EVHC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Offices & clinics of medical doctors


Debt-to-Equity Ratio0.65
Current Ratio2.27
Quick Ratio2.25


Trailing P/E Ratio18.02
Forward P/E Ratio13.11
P/E Growth1.1

Sales & Book Value

Annual Sales$12.18 billion
Price / Sales0.44
Cash Flow$6.2111 per share
Price / Cash7.20
Book Value$59.24 per share
Price / Book0.75


EPS (Most Recent Fiscal Year)$2.48
Net Income$-228,000,000.00
Net Margins1.41%
Return on Equity4.59%
Return on Assets1.97%


Outstanding Shares121,130,000

Envision Healthcare (NYSE:EVHC) Frequently Asked Questions

What is Envision Healthcare's stock symbol?

Envision Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVHC."

How will Envision Healthcare's stock buyback program work?

Envision Healthcare declared that its board has authorized a stock repurchase program on Tuesday, September 19th 2017, which permits the company to buyback $250,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 4.5% of its stock through open market purchases. Stock buyback programs are often a sign that the company's board of directors believes its shares are undervalued.

How were Envision Healthcare's earnings last quarter?

Envision Healthcare (NYSE:EVHC) announced its earnings results on Monday, May, 7th. The company reported $0.71 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.64 by $0.07. The firm had revenue of $2.08 billion for the quarter, compared to analyst estimates of $2.02 billion. Envision Healthcare had a return on equity of 4.59% and a net margin of 1.41%. The firm's revenue was up 10.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.77 earnings per share. View Envision Healthcare's Earnings History.

When is Envision Healthcare's next earnings date?

Envision Healthcare is scheduled to release their next quarterly earnings announcement on Monday, August, 6th 2018. View Earnings Estimates for Envision Healthcare.

What guidance has Envision Healthcare issued on next quarter's earnings?

Envision Healthcare updated its FY18 earnings guidance on Monday, May, 7th. The company provided earnings per share guidance of $3.49-3.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.59. The company issued revenue guidance of $8.35-8.53 billion, compared to the consensus revenue estimate of $8.41 billion.Envision Healthcare also updated its Q2 guidance to $0.83-0.90 EPS.

What price target have analysts set for EVHC?

16 Wall Street analysts have issued 1-year price targets for Envision Healthcare's shares. Their forecasts range from $31.00 to $51.00. On average, they anticipate Envision Healthcare's share price to reach $41.30 in the next twelve months. View Analyst Ratings for Envision Healthcare.

What are Wall Street analysts saying about Envision Healthcare stock?

Here are some recent quotes from research analysts about Envision Healthcare stock:
  • 1. According to Zacks Investment Research, "Envision Healthcare’s first-quarter earnings beat the Zacks Consensus Estimate by 14%. The bottom line was however, down 5.8% year over year. Better-than-expected earnings were driven by revenue growth at the company’s Physicians Services segment. The stock has outperformed the industry in the past six months. The company has taken some discrete actions to improve its operating performance. It is optimistic about the physician services market, witnessing consolidation. Also, the divestiture of its AMR business will help the company focus on its core operations. However, the company suffers high leverage, leading to increased interest ratio. Its operating expense is exceeding the revenue growth and exerting pressure on the operating margins." (5/11/2018)
  • 2. Canaccord Genuity analysts commented, "We reiterate our BUY rating and raise our PT to $46 based on an improving financial outlook given restructuring and easing utilization headwinds. The company characterized guidance as highly visible and not heroic. As such, we recommend continued exposure as utilization headwinds dissipate and the operational improvement plan takes hold. Key positive: High visibility into 2018 guidance: The low-end of 2018 adj-EBITDA of $960M is 87% in hand when annualizing 4Q’17. M&A from 2017 and 2018 should contribute an incremental $10-$15M and $20-$30M, respectively, bringing visibility up to 92% coverage at the low-end. Organic growth and further expense benefits from operational improvements would be the last leg in getting to guidance. Key negative: Consolidated organic growth rate lowered to 2-5% (was 3-6%) taking into account a softer utilization environment." (2/28/2018)
  • 3. Cantor Fitzgerald analysts commented, "Revised 2018 estimates. We are lowering our 2018 adjusted EPS estimate to $3.75 from $3.95 and bringing down our adjusted 2018 EBITDA estimate to $950.6 million from $982 million to account for slightly higher seasonality, primarily in terms of salary, wages and benefits, which account for the majority of EVHC’s operating expenses. Our new estimate is just below the $960 million midpoint of management’s potential 2018 performance, as outlined in a presentation last November, but it remains above the $925.1 million FactSet consensus." (2/21/2018)

Who are some of Envision Healthcare's key competitors?

Who are Envision Healthcare's key executives?

Envision Healthcare's management team includes the folowing people:
  • Mr. William A. Sanger, Exec. Chairman (Age 68)
  • Mr. Christopher A. Holden, CEO, Pres & Director (Age 54)
  • Ms. Claire M. Gulmi, Advisor (Age 64)
  • Mr. Kevin D. Eastridge, Exec. VP & CFO (Age 53)
  • Mr. Karey Lynn Witty, Exec. VP & COO (Age 53)

Has Envision Healthcare been receiving favorable news coverage?

News headlines about EVHC stock have been trending somewhat positive on Tuesday, according to Accern Sentiment. Accern rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Envision Healthcare earned a news sentiment score of 0.06 on Accern's scale. They also assigned news headlines about the company an impact score of 46.47 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Who are Envision Healthcare's major shareholders?

Envision Healthcare's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.56%), Dimensional Fund Advisors LP (1.97%), Roystone Capital Management LP (1.75%), Neuberger Berman Group LLC (1.46%), JPMorgan Chase & Co. (1.39%) and Royal Bank of Canada (1.39%). Company insiders that own Envision Healthcare stock include John Thomas Gawaluck and Robert Jon Coward. View Institutional Ownership Trends for Envision Healthcare.

Which institutional investors are selling Envision Healthcare stock?

EVHC stock was sold by a variety of institutional investors in the last quarter, including Citigroup Inc., Guggenheim Capital LLC, State of Tennessee Treasury Department, Honeywell International Inc., Clearline Capital LP, Dimensional Fund Advisors LP, Segall Bryant & Hamill LLC and BlackRock Inc.. View Insider Buying and Selling for Envision Healthcare.

Which institutional investors are buying Envision Healthcare stock?

EVHC stock was acquired by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Roystone Capital Management LP, Boston Partners, UBS Group AG, Farallon Capital Management LLC, FIL Ltd, 12th Street Asset Management Company LLC and Neuberger Berman Group LLC. View Insider Buying and Selling for Envision Healthcare.

How do I buy shares of Envision Healthcare?

Shares of EVHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Envision Healthcare's stock price today?

One share of EVHC stock can currently be purchased for approximately $44.69.

How big of a company is Envision Healthcare?

Envision Healthcare has a market capitalization of $5.41 billion and generates $12.18 billion in revenue each year. The company earns $-228,000,000.00 in net income (profit) each year or $2.48 on an earnings per share basis. Envision Healthcare employs 69,300 workers across the globe.

How can I contact Envision Healthcare?

Envision Healthcare's mailing address is 1A BURTON HILLS BOULEVARD, NASHVILLE TN, 37215. The company can be reached via phone at 615-665-1283 or via email at [email protected]

MarketBeat Community Rating for Envision Healthcare (EVHC)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  479 (Vote Outperform)
Underperform Votes:  259 (Vote Underperform)
Total Votes:  738
MarketBeat's community ratings are surveys of what our community members think about Envision Healthcare and other stocks. Vote "Outperform" if you believe EVHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.